Huang Junjie, Chan Erica On-Ting, Liu Xianjing, Lok Veeleah, Ngai Chun Ho, Zhang Lin, Xu Wanghong, Zheng Zhi-Jie, Chiu Peter Ka-Fung, Vasdev Nikhil, Enikeev Dmitry, Shariat Shahrokh F, Ng Chi-Fai, Teoh Jeremy Yuen-Chun, Wong Martin C S
Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China; Centre for Health Education and Health Promotion, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
S.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Clin Genitourin Cancer. 2023 Aug;21(4):e261-e270.e50. doi: 10.1016/j.clgc.2023.02.003. Epub 2023 Feb 15.
We aimed to examine the global disease burden and trends of prostate cancer incidence and mortality by age, and their associations with gross domestic product (GDP), human development index (HDI), smoking, and alcohol drinking.
We retrieved the Global Cancer Observatory (GLOBOCAN) database for the incidence and mortality of prostate cancer in 2020; the World Bank for GDP per capita; the United Nations for HDI; the WHO Global Health Observatory for prevalence of smoking and alcohol drinking; the Cancer Incidence in 5 Continents (CI5), WHO mortality database, for trend analysis. We presented the prostate cancer incidence and mortality using age-standardized rates. We examined their associations with GDP, HDI, smoking, and alcohol drinking by Spearman's correlations and multivariable regression. We estimated the 10-year trend of incidence and mortality by joinpoint regression analysis with average annual percent change with 95% confidence intervals in different age groups.
A wide variation in the burden of prostate cancer with the highest mortality found in low-income countries while the highest incidence was observed in high-income countries. We found moderate to high positive correlations for GDP, HDI, and alcohol drinking with prostate cancer incidence, whilst a low negative correlation was observed for smoking. Globally, there was an increasing incidence but decreasing mortality of prostate cancer, and such trends were particularly prominent in Europe. Notably, the incidence increase was also found in the younger population aged <50 years.
There was a global variation in the burden of prostate cancer associated with GDP, HDI, smoking, and alcohol drinking.
我们旨在研究前列腺癌发病率和死亡率的全球疾病负担及按年龄划分的趋势,以及它们与国内生产总值(GDP)、人类发展指数(HDI)、吸烟和饮酒之间的关联。
我们检索了全球癌症观测站(GLOBOCAN)数据库中2020年前列腺癌的发病率和死亡率;世界银行的人均GDP数据;联合国的人类发展指数数据;世界卫生组织全球卫生观测站的吸烟和饮酒流行率数据;以及《五大洲癌症发病率》(CI5)、世界卫生组织死亡率数据库用于趋势分析。我们使用年龄标准化率展示前列腺癌的发病率和死亡率。我们通过斯皮尔曼相关性分析和多变量回归分析研究它们与GDP、HDI、吸烟和饮酒之间的关联。我们通过连接点回归分析估计不同年龄组发病率和死亡率的10年趋势,得出平均年度百分比变化及95%置信区间。
前列腺癌负担存在广泛差异,低收入国家的死亡率最高,而高收入国家的发病率最高。我们发现GDP、HDI和饮酒与前列腺癌发病率呈中度到高度正相关,而吸烟与前列腺癌发病率呈低度负相关。在全球范围内,前列腺癌的发病率在上升,但死亡率在下降,这种趋势在欧洲尤为明显。值得注意的是,在年龄小于50岁的较年轻人群中也发现了发病率上升的情况。
前列腺癌负担在全球范围内存在差异,且与GDP、HDI、吸烟和饮酒有关。